Urinalysis Market worth $4.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

News provided by

17 Aug, 2021, 15:30 GMT

CHICAGO, Aug. 17, 2021 /PRNewswire/ -- According to the new market research report "Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a 7.2% CAGR.

Browse in-depth TOC on "Urinalysis Market"
229 – Tables
44 – Figures
243 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

The increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests are factors supporting the growth of this market. Growth opportunities in emerging economies provide lucrative opportunities for the players operating in the market.

The consumables segment accounted for the largest share of market, by product segment, in 2020

Based on product, the urinalysis market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

Sediment urinalysis segment to register the highest CAGR during the forecast period

Based on the test type, the market has been segmented into pregnancy & fertility tests, biochemical urinalysis and sediment urinalysis. In 2020, the sediment urinalysis segment accounted for the highest CAGR. This can be primarily attributed to the increasing adoption of automated devices for sediment analysis.

The disease screening segment accounted for the largest share of the urinalysis market, by application segment, in 2020

Based on application, the market is segmented into disease screening and pregnancy & fertility. In 2020, the disease screening segment accounted for the largest share of this market. Factors such as the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide are driving the growth of this market.

The diagnostic laboratories segment accounted for the largest share of market, by end user segment, in 2020

Based on end user, the urinalysis market has been segmented into diagnostic laboratories, hospitals and clinics, home care settings and research laboratories & institutes. In 2020, diagnostic laboratories accounted for the largest share of the market. Diagnostic laboratories command the major share of the market owing to rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

North America is the largest regional market for urinalysis market

The urinalysis market is segmented into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of this region can be attributed to growing geriatric population, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments.

The major players operating in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (UK), Alphatech Scientitfic (Peru), Teco Diagnostics (US), Analyticon Technologies AG (Germany), Bioway Biological Technology Co. Ltd. (China), High Technology Inc. (US) and Agappe Diagnostics Ltd. (India).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=153479294

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) – Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/clinical-chemistry-analyzer-market-144027310.html

Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), End user (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/albumin-creatinine-tests-market-156696568.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/urinalysis-systems-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/urinalysis-systems.asp